Theranostics

- Professor Minseok Kim’s team at the DGIST confirmed the excellent anticancer effects of the NK cell therapy product that can self-activate in preclinical trials with CT Cells - This work is expected to be applied in various fields as a next-generation anticancer therapy using NK cells

A machine rapidly and robustly separates cancer cells from blood samples, overcoming challenges with currently available techniques.